诺普信(002215) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 reached ¥2,101,217,371.49, representing a 15.01% increase compared to ¥1,826,962,263.49 in the same period last year[6]. - Net profit attributable to shareholders was ¥626,925,211.01, a 37.99% increase from ¥454,314,295.21 year-on-year[6]. - Basic earnings per share rose to ¥0.6398, reflecting a 39.66% increase from ¥0.4581 in the same period last year[6]. - Operating profit for the current period was ¥647,929,041.63, up 44% from ¥451,244,724.87 in the previous period[28]. - Net profit attributable to the parent company was ¥626,925,211.01, representing a 38% increase from ¥454,314,295.21 in the previous period[28]. - Earnings per share (basic) increased to 0.6398 from 0.4581, reflecting a growth of 39.5%[29]. Assets and Liabilities - Total assets at the end of Q1 2025 were ¥12,026,330,736.67, a 7.09% increase from ¥11,229,976,236.79 at the end of the previous year[6]. - The company's equity attributable to shareholders increased by 16.52% to ¥4,464,585,012.61 from ¥3,831,480,194.32 at the end of the previous year[6]. - Current assets totaled CNY 4,683,638,016.55, up from CNY 4,519,318,182.93, indicating a growth of approximately 3.64%[23]. - Total liabilities amounted to CNY 7,320,120,543.94, compared to CNY 7,150,788,327.75 at the beginning of the period, marking an increase of approximately 2.37%[24]. - Non-current liabilities totaled CNY 1,911,926,545.03, up from CNY 1,699,052,125.86, reflecting an increase of approximately 12.48%[24]. Cash Flow - The net cash flow from operating activities decreased by 38.53% to ¥270,472,560.32, down from ¥439,983,306.19 in the previous year[6]. - Cash flow from operating activities generated a net amount of ¥270,472,560.32, down 38% from ¥439,983,306.19 in the previous period[31]. - The net cash flow from investing activities was -$304.39 million, slightly improved from -$305.44 million in the previous period[33]. - The net cash flow from financing activities was -$52.37 million, a decline from a positive $118.72 million last year[33]. - The net increase in cash and cash equivalents was -$86.24 million, contrasting with a positive increase of $253.28 million in the previous year[33]. - The ending balance of cash and cash equivalents was $723.31 million, down from $1.06 billion at the end of the previous period[33]. Sales and Revenue Drivers - The increase in revenue was driven by a ¥160 million increase in fresh consumption business sales, growing by 16.94%, and a ¥124 million increase in pesticide formulation sales, growing by 17.16%[14]. - The company reported a significant increase in accounts receivable, which rose by 94.67% to ¥100,702.31 million, primarily due to seasonal sales increases[12]. - The company has shown a significant increase in accounts receivable, which may indicate improved sales performance or changes in credit policy[22]. Expenses - Research and development expenses were ¥29,895,585.05, a decrease of 14% compared to ¥34,817,351.53 in the previous period[28]. - The company reported a decrease in sales expenses to ¥162,037,573.23 from ¥168,147,437.87, a reduction of about 3%[28]. Future Plans and Changes - The company plans to continue expanding its fresh consumption blueberry business, which has shown significant growth in sales volume[12]. - The company did not undergo an audit for the first quarter report[34]. - The new accounting standards will be first implemented starting in 2025[34].